Physician profile
Jack E Jensen
NPI 1295733285
$2,363.58
in general payments reported to CMS, 2019-2025
26 companies · $470 in 2025
The $470 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $353 · 2020: $361 · 2021: $473 · 2022: $199 · 2023: $361 · 2024: $146 · 2025: $470.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $957 · Education: $19.69.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $957.10 |
| Education | $19.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $391.40 | 2019-2023 | Krystexxa |
| Bioventus LLC | $313.65 | 2020-2025 | Gelsyn-3, Xcell, Exogen Ultrasound Bone Healing System |
| Pacira Pharmaceuticals Incorporated | $263.53 | 2019-2023 | Iovera, Zilretta, Exparel |
| Ferring Pharmaceuticals INC. | $238.57 | 2019-2025 | Euflexxa |
| Spinesmith Holdings, LLC | $167.40 | 2019 | |
| Stryker Corporation | $150.82 | 2021 | |
| Depuy Synthes Sales INC. | $114.32 | 2019-2024 | Monovisc, Orthovisc |
| Curonix LLC | $108.29 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Sanofi-Aventis U.S. LLC | $80.57 | 2022-2023 | |
| Zyla Life Sciences, INC. | $78.56 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $64.09 | 2022 | |
| Ermi LLC | $47.99 | 2020-2021 | |
| Pacira Therapeutics, INC. | $42.65 | 2021 | |
| Moximed, INC | $39.39 | 2025 | Misha Knee System, Small, Left |
| Fidia Pharma USA INC. | $37.81 | 2025 | Triluron, Hymovis |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $32.20 | 2020 | |
| Ossio INC | $26.77 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $24.85 | 2025 | |
| Baudax Bio INC. | $24.21 | 2020 | |
| Breg, INC | $19.69 | 2025 | |
| Ibsa Pharma INC. | $18.55 | 2025 | Tirosint, Licart, Flector |
| Orthogenrx INC. | $16.96 | 2020 | |
| Innovation Technologies INC | $16.26 | 2025 | Irrisept |
| Zimmer Biomet Holdings, INC. | $15.07 | 2022 | |
| Electronic Waveform Lab, INC. | $15.06 | 2021 | |
| Amgen INC. | $14.92 | 2025 | Krystexxa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jack Jensen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.